White Paper

Why NGS ELN Deployments Fail: Don’t Make These Mistakes

Why NGS ELN Deployments Fail: Don’t Make These Mistakes

Why NGS ELN Deployments Fail: Don’t Make These Mistakes

NGS has become essential in biopharma research, but many ELN deployments fail due to avoidable mistakes that disrupt workflows. Common pitfalls include choosing generic ELNs that lack NGS‑specific capabilities, relying on fragmented systems that scatter data, and neglecting training or ongoing optimization. Labs also struggle when they over‑customize rigid platforms or ignore scalability and real‑time monitoring needs. Effective NGS support requires robust sample and materials tracking, integrated workflows, and flexible systems that evolve with advancing sequencing methods.

Join for free to read